Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Antitumor effects demonstrated for rapamycin at immunosuppressive doses

Feb. 5, 2002

Health Canada clears Cytovax to initiate phase I trial of Cytovaxine

Jan. 23, 2002

Sweden expands approved use of Viragen's natural interferon alfa

Jan. 22, 2002

Macrolides for use as immunosuppressants in inflammatory conditions described in Novartis patent

Jan. 21, 2002

Efficacy of novel mucosal vaccine delivery system described by RxKinetix in recent article

Jan. 18, 2002

Antex extends manufacturing agreement for vaccines

Jan. 17, 2002

Positive preliminary results from Corixa's phase III trial of RC-529 adjuvant

Jan. 15, 2002

Epimmune and Rhein Biotech enter research agreement for vaccine development

Jan. 11, 2002

Genencor and Johns Hopkins form strategic research collaboration

Jan. 9, 2002

IND submitted for AGI-1096 in prevention of organ transplant rejection

Jan. 8, 2002

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...